Literature DB >> 30579548

An Original Case of an Association of Eosinophilic Fasciitis with Cholangitis Induced by Nivolumab.

Erwan Le Tallec1, Charles Ricordel2, Louise Triquet3, Arnaud Deniel4, Pascale Marcorelles5, Hervé Lena6, Patrick Jego7, Nicolas Belhomme8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30579548     DOI: 10.1016/j.jtho.2018.09.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

1.  Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management.

Authors:  Borui Pi; Jin Wang; Yifan Tong; Qiao Yang; Fangfang Lv; Yunsong Yu
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

2.  Eosinophilic Fasciitis with Concurrent Necrobiotic Granulomatous Dermatitis Related to Checkpoint Inhibition Therapy.

Authors:  Adeeb Haroon; Joseph Tadros; Emily H Smith
Journal:  J Immunother Precis Oncol       Date:  2022-01-20

Review 3.  Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.

Authors:  Karmela Kim Chan; Cynthia Magro; Alexander Shoushtari; Charles Rudin; Veronica Rotemberg; Anthony Rossi; Cecilia Lezcano; John Carrino; David Fernandez; Michael A Postow; Arlyn Apollo; Mario E Lacouture; Anne R Bass
Journal:  Oncologist       Date:  2019-10-15

4.  Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression.

Authors:  Ai-Tram N Bui; Caroline A Nelson; Christine G Lian; Alvaro Laga Canales; Nicole R LeBoeuf
Journal:  JAAD Case Rep       Date:  2020-04-25

5.  Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced "Eosinophilic Fasciitis-Like" Case and a Review of the Literature.

Authors:  Christina Salamaliki; Elena E Solomou; Stamatis-Nick C Liossis
Journal:  Rheumatol Ther       Date:  2020-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.